Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity - Couto Alves, A; Valcarcel, B; Mäkinen, V-P; Morin-Papunen, L; Sebert, S; Kangas, A J; Soininen, P; Das, S; De Iorio, M; Coin, L; Ala-Korpela, M; Järvelin, M-R; et al. (International Journal of Obesity, 2017)
Keywords: 631/443/319/1642; 631/45/320; 692/163/2743/393; 692/699/2743/1526/1744; Adult; Albumin; Androgens; Care and treatment; Comparative analysis; Diabetes mellitus; Diagnosis; Dyslipidemia; Dyslipidemias - epidemiology; Dyslipidemias - etiology; Dyslipidemias - metabolism; Epidemiology; Evaluation Studies as Topic; Female; Finland - epidemiology; Health aspects; Health Promotion and Disease Prevention; High density lipoprotein; Humans; Hyperandrogenism - epidemiology; Hyperandrogenism - metabolism; Hyperandrogenism - physiopathology; Insulin; Insulin - metabolism; Insulin resistance; Insulin Resistance - physiology; Internal Medicine; Lipids; Lipoproteins (very low density); Medicine; Medicine & Public Health; Metabolic Diseases; Metabolism; Metabolites; Metabolomics; NMR; Nuclear magnetic resonance; Obesity; Obesity, Abdominal - epidemiology; Obesity, Abdominal - metabolism; Obesity, Abdominal - physiopathology; Original; original-article; Polycystic ovary syndrome; Polycystic Ovary Syndrome - epidemiology; Polycystic Ovary Syndrome - metabolism; Polycystic Ovary Syndrome - physiopathology; Public Health; Serum lipids; Strata; Testosterone; Testosterone - metabolism; Waist Circumference - physiology; Womens health